De Novo VPS4A Mutations Cause Multisystem Disease with Abnormal Neurodevelopment.


Journal

American journal of human genetics
ISSN: 1537-6605
Titre abrégé: Am J Hum Genet
Pays: United States
ID NLM: 0370475

Informations de publication

Date de publication:
03 12 2020
Historique:
received: 01 07 2020
accepted: 26 10 2020
pubmed: 14 11 2020
medline: 13 1 2021
entrez: 13 11 2020
Statut: ppublish

Résumé

The endosomal sorting complexes required for transport (ESCRTs) are essential for multiple membrane modeling and membrane-independent cellular processes. Here we describe six unrelated individuals with de novo missense variants affecting the ATPase domain of VPS4A, a critical enzyme regulating ESCRT function. Probands had structural brain abnormalities, severe neurodevelopmental delay, cataracts, growth impairment, and anemia. In cultured cells, overexpression of VPS4A mutants caused enlarged endosomal vacuoles resembling those induced by expression of known dominant-negative ATPase-defective forms of VPS4A. Proband-derived fibroblasts had enlarged endosomal structures with abnormal accumulation of the ESCRT protein IST1 on the limiting membrane. VPS4A function was also required for normal endosomal morphology and IST1 localization in iPSC-derived human neurons. Mutations affected other ESCRT-dependent cellular processes, including regulation of centrosome number, primary cilium morphology, nuclear membrane morphology, chromosome segregation, mitotic spindle formation, and cell cycle progression. We thus characterize a distinct multisystem disorder caused by mutations affecting VPS4A and demonstrate that its normal function is required for multiple human developmental and cellular processes.

Identifiants

pubmed: 33186545
pii: S0002-9297(20)30370-0
doi: 10.1016/j.ajhg.2020.10.012
pmc: PMC7820634
pii:
doi:

Substances chimiques

Endosomal Sorting Complexes Required for Transport 0
Vacuolar Proton-Translocating ATPases EC 3.6.1.-
ATPases Associated with Diverse Cellular Activities EC 3.6.4.-
VPS4A protein, human EC 3.6.4.6
VPS4B protein, human EC 3.6.4.6
Vps4b protein, mouse EC 3.6.4.6

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1129-1148

Subventions

Organisme : Wellcome Trust
ID : 093026
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 216370/Z/19/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M00046X/1
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R026440/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 100140
Pays : United Kingdom

Informations de copyright

Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Références

Nat Rev Mol Cell Biol. 2020 Jan;21(1):25-42
pubmed: 31705132
Dev Cell. 2002 Aug;3(2):283-9
pubmed: 12194858
Mol Biol Cell. 2000 Jan;11(1):227-39
pubmed: 10637304
Cell Microbiol. 2007 Dec;9(12):2955-67
pubmed: 17760879
Elife. 2016 Sep 23;5:
pubmed: 27661255
Cell. 2012 Jul 6;150(1):122-35
pubmed: 22770216
Nat Rev Mol Cell Biol. 2017 Jan;18(1):5-17
pubmed: 27703243
J Cell Biol. 2006 Mar 27;172(7):1045-56
pubmed: 16567502
Nature. 2015 Jun 11;522(7555):231-5
pubmed: 26040712
Brain. 2012 Mar;135(Pt 3):819-32
pubmed: 22366797
Curr Protoc Cell Biol. 2018 Jun;79(1):e51
pubmed: 29924488
Nucleic Acids Res. 2019 Jan 8;47(D1):D520-D528
pubmed: 30357364
Elife. 2019 Jun 11;8:
pubmed: 31184588
Traffic. 2008 Dec;9(12):2180-9
pubmed: 18796009
Cell. 2001 Jul 27;106(2):145-55
pubmed: 11511343
J Cell Sci. 2003 Jan 15;116(Pt 2):401-14
pubmed: 12482925
Nat Genet. 2003 May;34(1):59-64
pubmed: 12669066
Mol Biol Cell. 2000 Feb;11(2):747-63
pubmed: 10679028
Dev Cell. 2002 Aug;3(2):271-82
pubmed: 12194857
Sci Rep. 2018 Feb 20;8(1):3353
pubmed: 29463826
EMBO J. 2005 Oct 19;24(20):3658-69
pubmed: 16193069
Biochim Biophys Acta. 2012 Jan;1823(1):2-14
pubmed: 21839118
Am J Hum Genet. 2018 Oct 4;103(4):621-630
pubmed: 30290154
J Mol Biol. 2001 Sep 21;312(3):469-80
pubmed: 11563910
Mol Genet Genomic Med. 2020 Jul;8(7):e1106
pubmed: 32347641
Nature. 2004 Nov 18;432(7015):316-23
pubmed: 15549093
Nature. 2020 May;581(7809):434-443
pubmed: 32461654
Proc Natl Acad Sci U S A. 2010 Jul 20;107(29):12889-94
pubmed: 20616062
Biochem Soc Trans. 2019 Feb 28;47(1):441-448
pubmed: 30783012
Transl Neurodegener. 2015 Sep 30;4:18
pubmed: 26448863
Mol Biol Cell. 2009 Mar;20(5):1374-87
pubmed: 19129480
Nat Genet. 2005 Aug;37(8):806-8
pubmed: 16041373
Traffic. 2014 Feb;15(2):197-211
pubmed: 24279430
Nature. 2015 Jun 11;522(7555):236-9
pubmed: 26040713
Nat Commun. 2018 Aug 23;9(1):3379
pubmed: 30139939
Curr Opin Cell Biol. 2007 Apr;19(2):238-45
pubmed: 17303408
ACS Chem Biol. 2018 Feb 16;13(2):406-416
pubmed: 29035510
J Cell Biol. 2013 Aug 5;202(3):527-43
pubmed: 23897888
J Cell Biol. 2017 May 1;216(5):1337-1355
pubmed: 28389476
Science. 2015 Dec 18;350(6267):1548-51
pubmed: 26634441
Nat Genet. 2012 Nov;44(11):1260-4
pubmed: 23023333
Science. 2016 Apr 15;352(6283):359-62
pubmed: 27013426
Nat Struct Mol Biol. 2008 Dec;15(12):1278-86
pubmed: 18997780
Mol Biol Cell. 2006 Jun;17(6):2513-23
pubmed: 16554368
Dev Cell. 2018 Dec 3;47(5):547-563.e6
pubmed: 30513301
Am J Hum Genet. 2019 Sep 5;105(3):493-508
pubmed: 31447100
Curr Opin Neurobiol. 2004 Feb;14(1):112-7
pubmed: 15018946
Nature. 2007 Oct 11;449(7163):740-4
pubmed: 17928862
Neuron. 2019 Oct 23;104(2):239-255.e12
pubmed: 31422865
Nature. 2007 Oct 11;449(7163):735-9
pubmed: 17928861
Elife. 2015 May 26;4:e06547
pubmed: 26011858
Nat Rev Mol Cell Biol. 2004 Feb;5(2):121-32
pubmed: 15040445
Traffic. 2009 Jan;10(1):42-56
pubmed: 19000169
Am J Hum Genet. 2020 Dec 3;107(6):1149-1156
pubmed: 33186543
Am J Hum Genet. 2007 Sep;81(3):596-606
pubmed: 17701905
Intensive Care Med. 2019 May;45(5):627-636
pubmed: 30847515
Nature. 2020 Jul;583(7814):96-102
pubmed: 32581362
Dev Cell. 2006 Mar;10(3):343-54
pubmed: 16516837
Hum Mutat. 2015 Oct;36(10):928-30
pubmed: 26220891
Stem Cell Reports. 2017 Oct 10;9(4):1221-1233
pubmed: 28966121
Annu Rev Cell Dev Biol. 2018 Oct 6;34:85-109
pubmed: 30095293
Nat Genet. 2019 Jan;51(1):88-95
pubmed: 30531870
Nat Struct Mol Biol. 2009 Jul;16(7):754-62
pubmed: 19525971
Nat Rev Mol Cell Biol. 2017 Sep;18(9):533-547
pubmed: 28698599
Mol Cell Biol. 2012 Mar;32(6):1124-38
pubmed: 22252323
Nat Protoc. 2007;2(5):1084-104
pubmed: 17546000

Auteurs

Catherine Rodger (C)

Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, UK; Department of Medical Genetics, University of Cambridge, Cambridge CB2 0QQ, UK.

Elisabetta Flex (E)

Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome 00161, Italy.

Rachel J Allison (RJ)

Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, UK; Department of Medical Genetics, University of Cambridge, Cambridge CB2 0QQ, UK.

Alba Sanchis-Juan (A)

Department of Haematology, NHS Blood and Transplant Centre, University of Cambridge, Cambridge CB2 0XY, UK; NIHR BioResource, Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK.

Marcia A Hasenahuer (MA)

Department of Medical Genetics, University of Cambridge, Cambridge CB2 0QQ, UK; European Molecular Biology Laboratory - European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.

Serena Cecchetti (S)

Microscopy Area, Core Facilities, Istituto Superiore di Sanità, Rome 00161, Italy.

Courtney E French (CE)

Department of Medical Genetics, University of Cambridge, Cambridge CB2 0QQ, UK.

James R Edgar (JR)

Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, UK; Department of Pathology, University of Cambridge, Cambridge CB2 1QP, UK.

Giovanna Carpentieri (G)

Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome 00161, Italy; Genetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, IRCCS, Rome 00146, Italy.

Andrea Ciolfi (A)

Genetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, IRCCS, Rome 00146, Italy.

Francesca Pantaleoni (F)

Genetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, IRCCS, Rome 00146, Italy.

Alessandro Bruselles (A)

Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome 00161, Italy.
Genomics England, London, UK.

Roberta Onesimo (R)

Fondazione Policlinico Universitario A. Gemelli-IRCCS, Rome 00168, Italy.

Giuseppe Zampino (G)

Fondazione Policlinico Universitario A. Gemelli-IRCCS, Rome 00168, Italy; Università Cattolica del Sacro Cuore, Rome 00168, Italy.

Francesca Marcon (F)

Unit of Mechanisms, Biomarkers and Models, Department of Environment and Health, Istituto Superiore di Sanità, Rome 00161, Italy.

Ester Siniscalchi (E)

Unit of Mechanisms, Biomarkers and Models, Department of Environment and Health, Istituto Superiore di Sanità, Rome 00161, Italy.

Melissa Lees (M)

Department of Clinical Genetics, Great Ormond Street Hospital, London WC1N 3JH, UK.

Deepa Krishnakumar (D)

Department of Paediatric Neurology, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.

Emma McCann (E)

Department of Clinical Genetics, Liverpool Women's Hospital, Liverpool L8 7SS, UK.

Dragana Yosifova (D)

Department of Medical Genetics, Guys' and St Thomas' NHS Foundation Trust, London SE1 9RT, UK.

Joanna Jarvis (J)

Clinical Genetics, Birmingham Women's and Children's NHS Foundation Trust, Birmingham B15 2TG, UK.

Michael C Kruer (MC)

Phoenix Children's Hospital, Phoenix, AZ 76109, USA.

Warren Marks (W)

Cook Children's Medical Centre, Fort Worth, TX 76104, USA.

Jonathan Campbell (J)

Colchester Hospital, East Suffolk and North Essex NHS Foundation Trust, Essex CO4 5JL, UK.

Louise E Allen (LE)

Ophthalmology Department, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.

Stefano Gustincich (S)

Department of Neuroscience and Brain Technologies, Istituto Italiano di Tecnologia, Genova 16163, Italy; Area of Neuroscience, SISSA, Trieste 34136, Italy.

F Lucy Raymond (FL)

Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, UK; Department of Medical Genetics, University of Cambridge, Cambridge CB2 0QQ, UK.

Marco Tartaglia (M)

Genetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, IRCCS, Rome 00146, Italy. Electronic address: marco.tartaglia@opbg.net.

Evan Reid (E)

Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, UK; Department of Medical Genetics, University of Cambridge, Cambridge CB2 0QQ, UK. Electronic address: ealr4@cam.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH